INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 126,550 Value ($000) $2,346 Avg Close — Range —
Q2 2023
Shares 152,900 Value ($000) $1,691 Avg Close — Range —
Q1 2023
Shares 145,291 Value ($000) $1,951 Avg Close — Range —
Q4 2022
Shares 142,223 Value ($000) $1,759 Avg Close — Range —
Q3 2022
Shares 136,193 Value ($000) $1,900 Avg Close — Range —
Q2 2022
Shares 98,036 Value ($000) $1,354 Avg Close — Range —
Q1 2022
Shares 106,843 Value ($000) $1,738 Avg Close — Range —
Q4 2021
Shares 117,629 Value ($000) $1,916 Avg Close — Range —
Q3 2021
Shares 118,095 Value ($000) $1,754 Avg Close — Range —
Q2 2021
Shares 119,996 Value ($000) $2,396 Avg Close — Range —
Q1 2021
Shares 111,045 Value ($000) $2,563 Avg Close — Range —
Q4 2014
Shares 4,300 Value ($000) $671 Avg Close — Range —